Matches in Nanopublications for { ?s ?p "[MDR1 promoter methylation and P-gp expression were assessed in 121 PCa, 39 high-grade prostatic intraepithelial neoplasia (HGPIN), 28 benign prostatic hyperplasia (BPH) and 10 morphologically normal prostate tissue (NPT) samples, using quantitative methylation specific PCR and immunohistochemistry, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618967.RAP465IP4dF9P0fEq0lMGo4DwordHz5B_louwp_HceU4M130_assertion description "[MDR1 promoter methylation and P-gp expression were assessed in 121 PCa, 39 high-grade prostatic intraepithelial neoplasia (HGPIN), 28 benign prostatic hyperplasia (BPH) and 10 morphologically normal prostate tissue (NPT) samples, using quantitative methylation specific PCR and immunohistochemistry, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618967.RAP465IP4dF9P0fEq0lMGo4DwordHz5B_louwp_HceU4M130_provenance.
- assertion description "[MDR1 promoter methylation and P-gp expression were assessed in 121 PCa, 39 high-grade prostatic intraepithelial neoplasia (HGPIN), 28 benign prostatic hyperplasia (BPH) and 10 morphologically normal prostate tissue (NPT) samples, using quantitative methylation specific PCR and immunohistochemistry, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MDR1 promoter methylation and P-gp expression were assessed in 121 PCa, 39 high-grade prostatic intraepithelial neoplasia (HGPIN), 28 benign prostatic hyperplasia (BPH) and 10 morphologically normal prostate tissue (NPT) samples, using quantitative methylation specific PCR and immunohistochemistry, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1137506.RAHSbVVJDKAHtscnSDo1PZcsRr5ei9vpk6pjKvxtJQsGo130_assertion description "[MDR1 promoter methylation and P-gp expression were assessed in 121 PCa, 39 high-grade prostatic intraepithelial neoplasia (HGPIN), 28 benign prostatic hyperplasia (BPH) and 10 morphologically normal prostate tissue (NPT) samples, using quantitative methylation specific PCR and immunohistochemistry, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1137506.RAHSbVVJDKAHtscnSDo1PZcsRr5ei9vpk6pjKvxtJQsGo130_provenance.
- NP869509.RAK2Q8ji_-KTBLZaX8dRoKT8hLxpsj4c-lRn5_Y0DCj00130_assertion description "[MDR1 promoter methylation and P-gp expression were assessed in 121 PCa, 39 high-grade prostatic intraepithelial neoplasia (HGPIN), 28 benign prostatic hyperplasia (BPH) and 10 morphologically normal prostate tissue (NPT) samples, using quantitative methylation specific PCR and immunohistochemistry, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869509.RAK2Q8ji_-KTBLZaX8dRoKT8hLxpsj4c-lRn5_Y0DCj00130_provenance.
- NP1137507.RAg60tWb_LSThyxQnwkg495nANWScUnB2yXSx27ObMiLY130_assertion description "[MDR1 promoter methylation and P-gp expression were assessed in 121 PCa, 39 high-grade prostatic intraepithelial neoplasia (HGPIN), 28 benign prostatic hyperplasia (BPH) and 10 morphologically normal prostate tissue (NPT) samples, using quantitative methylation specific PCR and immunohistochemistry, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1137507.RAg60tWb_LSThyxQnwkg495nANWScUnB2yXSx27ObMiLY130_provenance.